000 | 01998 a2200553 4500 | ||
---|---|---|---|
005 | 20250516072913.0 | ||
264 | 0 | _c20120611 | |
008 | 201206s 0 0 eng d | ||
022 | _a1549-490X | ||
024 | 7 |
_a10.1634/theoncologist.2011-0276 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorice, Philippe | |
245 | 0 | 0 |
_aResults of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer. _h[electronic resource] |
260 |
_bThe oncologist _c2012 |
||
300 |
_a64-71 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aBrachytherapy |
650 | 0 | 4 | _aChemoradiotherapy, Adjuvant |
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHysterectomy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xpathology |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aRouanet, Philippe | |
700 | 1 | _aRey, Annie | |
700 | 1 | _aRomestaing, Pascale | |
700 | 1 | _aHouvenaeghel, Gilles | |
700 | 1 | _aBoulanger, Jean Charles | |
700 | 1 | _aLeveque, Jean | |
700 | 1 | _aCowen, Didier | |
700 | 1 | _aMathevet, Patrice | |
700 | 1 | _aMalhaire, Jean Pierre | |
700 | 1 | _aMagnin, Guillaume | |
700 | 1 | _aFondrinier, Eric | |
700 | 1 | _aBerille, Jocelyne | |
700 | 1 | _aHaie-Meder, Christine | |
773 | 0 |
_tThe oncologist _gvol. 17 _gno. 1 _gp. 64-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.2011-0276 _zAvailable from publisher's website |
999 |
_c21451310 _d21451310 |